Quantitative modeling of the terminal differentiation of B cells and mechanisms of lymphomagenesis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 7, 2012, Pages 2672-2677

  Martínez, María Rodríguez ^a   Corradin, Alberto ^b   Klein, Ulf ^a   Álvarez, Mariano Javier ^a   Toffolo, Gianna M ^b   Di Camillo, Barbara ^b   Califano, Andrea ^a   Stolovitzky, Gustavo A ^c  

^a Columbia University ^*  (United States)

^b UNIVERSITY OF PADOVA   (Italy)

^c IBM   (United States)

Author keywords

B cell differentiation; Gene regulatory networks; Immunity; Master regulators

Indexed keywords

B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; INTERFERON REGULATORY FACTOR 4; PROTEIN BCL 6;

ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; CARCINOGENESIS; CELL INTERACTION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HYSTERESIS; KINETICS; LYMPHOMA; LYMPHOMAGENESIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE STUDY;

B-LYMPHOCYTES; CELL DIFFERENTIATION; GENE EXPRESSION PROFILING; HUMANS; IMMUNOLOGIC MEMORY; LYMPHOMA;

EID: 84857132752     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1113019109     Document Type: Article

References (44)

1. Liu Y-J, et al. (1989) Mechanism of antigen-driven selection in germinal centres. Nature 342:929-931. (Pubitemid 20021340)
2. Klein U, Dalla-Favera R (2008) Germinal centres: Role in B-cell physiology and malignancy. Nat Rev Immunol 8:22-33.
3. Dent AL, Shaffer AL, Yu X, Allman D, Staudt LM; Control of Inflammation, Cytokine Expression, and Germinal Center Formation by BCL-6 (1997) Control of inflammation, cytokine expression, and germinal center formation by BCL-6. Science 276:589-592. (Pubitemid 27193682)
4. Niu H, Ye BH, Dalla-Favera R (1998) Antigen receptor signaling induces MAP kinase-mediated phosphorylation and degradation of the BCL-6 transcription factor. Genes Dev 12:1953-1961. (Pubitemid 28323870)
5. Mittrücker H-W, et al. (1997) Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science 275:540-543. (Pubitemid 27051911)
6. Saito M, et al. (2007) A signaling pathway mediating downregulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterations in B cell lymphoma. Cancer Cell 12:280-292. (Pubitemid 47333420)
7. Sciammas R, et al. (2006) Graded expression of interferon regulatory factor-4 coordinates isotype switching with plasma cell differentiation. Immunity 25:225-236. (Pubitemid 44224149)
8. Turner CA, Jr., Mack DH, Davis MM (1994) Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cells. Cell 77:297-306. (Pubitemid 24138626)
9. Pasqualucci L, et al. (2003) Mutations of the BCL6 proto-oncogene disrupt its negative autoregulation in diffuse large B-cell lymphoma. Blood 101:2914-2923. (Pubitemid 36857975)
10. Basso K, et al. (2009) Integrated biochemical and computational approach identifies BCL6 direct target genes controlling multiple pathways in normal germinal-center B cells. Blood, 2009-06-227017.
11. Shaffer AL, et al. (2000) BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control. Immunity 13:199-212.
12. Pasqualucci L, et al. (2008) Inactivating mutations of acetyltransferase genes in B-cell lymphomas. Nature 471:189-195.
13. Bereshchenko OR, Gu W, Dalla-Favera R (2002) Acetylation inactivates the transcriptional repressor BCL6. Natl Genet 32:606-613. (Pubitemid 35435172)
14. Shaffer AL, et al. (2002) Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. Immunity 17:51-62. (Pubitemid 34874618)
15. Lin L, Gerth AJ, Peng SL (2004) Active inhibition of plasma cell development in resting B cells by microphthalmia-associated transcription factor. J Exp Med 200:115-122. (Pubitemid 38924734)
16. Shaffer AL, et al. (2008) IRF4 addiction in multiple myeloma. Nature 454:226-231. (Pubitemid 351969894)
17. Tyson JJ, Chen KC, Novak B (2003) Sniffers, buzzers, toggles and blinkers: Dynamics of regulatory and signaling pathways in the cell. Curr Opin Cell Biol 15:221-231. (Pubitemid 36332198)
18. Arpin C, et al. (1995) Generation of memory B cells and plasma cells in vitro. Science 268:720-722.
19. Tarlinton DM, Smith KGC (2000) Dissecting affinity maturation: A model explaining selection of antibody-forming cells and memory B cells in the germinal centre. Immunol Today 21:436-441.
20. Blink EJ, et al. (2005) Early appearance of germinal center-derived memory B cells and plasma cells in blood after primary immunization. J Exp Med 201:545-554. (Pubitemid 40289545)
21. Tarlinton D (2006) B-cell memory: Are subsets necessary? Nat Rev Immunol 6:785-790.
22. Klein U, et al. (2006) Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination. Nat Immunol 7:773-782. (Pubitemid 43905877)
23. Schebesta A, et al. (2007) Transcription factor Pax5 activates the chromatin of key genes involved in B cell signaling, adhesion, migration, and immune function. Immunity 27:49-63. (Pubitemid 47096800)
24. Mora-López F, Reales E, Brieva JA, Campos-Caro A (2007) Human BSAP and BLIMP1 conform an autoregulatory feedback loop. Blood 110:3150-3157. (Pubitemid 350106306)
25. Muto A, et al. (2010) Bach2 represses plasma cell gene regulatory network in B cells to promote antibody class switch. EMBO J 29:4048-4061.
26. Klein U, et al. (2006) Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination. Nat Immunol 7:773-782. (Pubitemid 43905877)
27. Sciammas R, et al. (2011) An incoherent regulatory network architecture that orchestrates B cell diversification in response to antigen signaling. Mol Syst Biol 7:495.
28. Phan RT, Dalla-Favera R (2004) The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells. Nature 432:635-639. (Pubitemid 39626271)
29. Ranuncolo SM, et al. (2007) Bcl-6 mediates the germinal center B cell phenotype and lymphomagenesis through transcriptional repression of the DNA-damage sensor ATR. Nat Immunol 8:705-714. (Pubitemid 46965346)
30. Alizadeh AA, et al. (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403:503-511. (Pubitemid 30082188)
31. Ye BH, et al. (1993) Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma. Science 262:747-750. (Pubitemid 23350695)
32. Lo Coco F, et al. (1994) Rearrangements of the BCL6 gene in diffuse large cell non-Hodgkin's lymphoma. Blood 83:1757-1759. (Pubitemid 24107897)
33. Pasqualucci L, et al. (2006) Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma. J Exp Med 203:311-317. (Pubitemid 43290840)
34. Tam W, et al. (2006) Mutational analysis of PRDM1 indicates a tumor-suppressor role in diffuse large B-cell lymphomas. Blood 107:4090-4100. (Pubitemid 43726818)
35. Mandelbaum J, et al. (2010) BLIMP1 is a tumor suppressor gene frequently disrupted in activated B cell-like diffuse large B cell lymphoma. Cancer Cell 18:568-579.
36. Lam LT, et al. (2005) Small molecule inhibitors of IkappaB kinase are selectively toxic for subgroups of diffuse large B-cell lymphoma defined by gene expression profiling. Clin Cancer Res 11:28-40. (Pubitemid 40075775)
37. Davis RE, et al. (2001) Constitutive Nuclear Factor êB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells. J Exp Med 194:1861-1874.
38. Lenz G, et al. (2008) Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways. Proc Natl Acad Sci USA 105:13520-13525.
39. Iqbal J, et al.; Leukemia/Lymphoma Molecular Profiling Project (2007) Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma. Leukemia 21:2332-2343. (Pubitemid 350011706)
40. Wang X, Li Z, Naganuma A, Ye BH (2002) Negative autoregulation of BCL-6 is bypassed by genetic alterations in diffuse large B cell lymphomas. Proc Natl Acad Sci USA 99:15018-15023. (Pubitemid 35334602)
41. Gupta S, et al. (1999) Lineage-specific modulation of interleukin 4 signaling by interferon regulatory factor 4. J Exp Med 190:1837-1848. (Pubitemid 30013849)
42. Compagno M, et al. (2009) Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma. Nature 459:717-721.
43. Lenz G, et al. (2008) Oncogenic CARD11 mutations in human diffuse large B cell lymphoma. Science 319:1676-1679. (Pubitemid 351432507)
44. Davis RE, et al. (2010) Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma. Nature 463:88-92.